80 related articles for article (PubMed ID: 2523588)
1. Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor.
Kahan BD; Kerman RH; Van Buren CT; Flechner SM; Golden DL; Lewis RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1579-80. PubMed ID: 2523588
[No Abstract] [Full Text] [Related]
2. Changes in donor-specific cell-mediated lympholysis (CML) response associated with success of early steroid withdrawal in DST-azathioprine-treated renal transplant recipients.
Burlingham WJ; Grailer A; Sollinger HW
Transplant Proc; 1989 Feb; 21(1 Pt 2):1818-9. PubMed ID: 2523595
[No Abstract] [Full Text] [Related]
3. Related donor kidney transplantation is the best form of treatment for uremia.
Groth CG; Fehrman I; Ringdén O; Lundgren G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
[No Abstract] [Full Text] [Related]
4. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
[No Abstract] [Full Text] [Related]
5. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients.
MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546
[TBL] [Abstract][Full Text] [Related]
6. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
[No Abstract] [Full Text] [Related]
7. In vitro donor-specific hyporesponsiveness and T cell subsets in renal allograft recipients.
Bas J; Mestre M; Griñó JM; Massip E; Castelao AM; Romeu A; González L; Valls A; Buendía E
Allergol Immunopathol (Madr); 1993; 21(4):136-40. PubMed ID: 8237717
[TBL] [Abstract][Full Text] [Related]
8. Prednisone withdrawal in HLA-identical living related donor transplant recipients.
Hariharan S; First MR; Munda R; Penn I; Schroeder TJ; Fidler J; Weiskittel P; Alexander JW
Transplant Proc; 1989 Feb; 21(1 Pt 2):1617-9. PubMed ID: 2652526
[No Abstract] [Full Text] [Related]
9. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
[TBL] [Abstract][Full Text] [Related]
10. Effect of donor-specific transfusions on renal transplantation in children.
Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O
Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
[No Abstract] [Full Text] [Related]
12. Donor-specific hyporesponsiveness is observed in renal transplant patients who successfully maintain their renal function more than 6 years.
Kim YK; Ha J; Park MH; Kim SJ
Transplant Proc; 1996 Jun; 28(3):1235-6. PubMed ID: 8658639
[No Abstract] [Full Text] [Related]
13. Renal transplantation from living donors mismatched for two HLA haplotypes.
Sødal G; Albrechtsen D; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Talseth T; Thorsby E; Flatmark A
Transplant Proc; 1987 Feb; 19(1 Pt 2):1509-10. PubMed ID: 3079022
[No Abstract] [Full Text] [Related]
14. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV
Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
[No Abstract] [Full Text] [Related]
15. Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation.
Ingulli E; Sharma V; Singh A; Suthanthiran M; Tejani A
Kidney Int Suppl; 1993 Oct; 43():S36-9. PubMed ID: 8246367
[TBL] [Abstract][Full Text] [Related]
16. [Results of transplantation of kidneys from related living donors].
Fassbinder W; Frei U; Schoeppe W; Dathe G; Jonas D; Knöner M; Weber W
Urologe A; 1982 Sep; 21(5):290-5. PubMed ID: 6217620
[TBL] [Abstract][Full Text] [Related]
17. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
[No Abstract] [Full Text] [Related]
18. The effects of donor specific transfusion and cyclosporine A on graft outcome.
Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N
Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506
[No Abstract] [Full Text] [Related]
19. Strategy for improvement of graft survival in kidney recipients of nonrelated living donors.
Távora ER; Lasmar EP; Vilaca SS; Figueiró JV; Bamberg A; Rocha LM; Costa MM; Bicalbo O; Souza E; Machado R
Transplant Proc; 1995 Apr; 27(2):1819-20. PubMed ID: 7725518
[No Abstract] [Full Text] [Related]
20. Renal transplantation between histocompatible donor-recipient pairs.
Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
